Profil
Robert Siegle is currently the Director at Stratec Biomedical, the Co-Managing Director at STRATEC PS Holding GmbH, a Member-Management Board at STRATEC NewGen GmbH, and a Member-Supervisory Board at both STRATEC Biomedical Switzerland AG and STRATEC Services AG.
He previously worked as a Member-Management Board at Invitek Molecular GmbH and as the Head-Finance & Human Resources at STRATEC SE.
Dr. Siegle holds a doctorate degree from Eberhard Karls Universität Tübingen.
Postes actifs de Robert Siegle
| Sociétés | Poste | Début |
|---|---|---|
Stratec Biomedical | Directeur/Membre du Conseil | 23/12/2012 |
STRATEC NewGen GmbH | Corporate Officer/Principal | 23/12/2012 |
Stratec Biomedical Switzerland AG | Directeur/Membre du Conseil | 01/03/2014 |
STRATEC PS Holding GmbH
STRATEC PS Holding GmbH Investment ManagersFinance Engages in management of assets | Directeur Général | 01/05/2016 |
Anciens postes connus de Robert Siegle
| Sociétés | Poste | Fin |
|---|---|---|
| STRATEC SE | Directeur Financier/CFO | 31/08/2024 |
STRATEC Services AG | Directeur/Membre du Conseil | 18/06/2024 |
Invitek Molecular GmbH
Invitek Molecular GmbH BiotechnologyHealth Technology Researches and develops diagnostic products and proprietary core technologies for nucleic acid extraction and analysis | Corporate Officer/Principal | - |
Formation de Robert Siegle
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
STRATEC SE
STRATEC SE Medical SpecialtiesHealth Technology Develops and manufactures fully automated analyzer systems in the fields of clinical diagnostics & biotechnology | Health Technology |
Eberhard Karls Universität Tübingen
Eberhard Karls Universität Tübingen Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Invitek Molecular GmbH
Invitek Molecular GmbH BiotechnologyHealth Technology Researches and develops diagnostic products and proprietary core technologies for nucleic acid extraction and analysis | Health Technology |
STRATEC NewGen GmbH | |
Stratec Biomedical | |
Stratec Biomedical Switzerland AG | |
STRATEC Services AG | |
STRATEC PS Holding GmbH
STRATEC PS Holding GmbH Investment ManagersFinance Engages in management of assets | Finance |
















